WASHINGTON (Reuters) – U.S. drugs regulators gave the nod to Astellas Pharma Inc‘s pill for overactive bladder on Thursday, boosting the Japanese drugmaker’s foothold in the market for the condition.
The Food and Drug Administration approved the once-daily pill, mirabegron, for adults who cannot control their bladder muscles, following a positive recommendation from FDA advisers.
(Reporting by Anna Yukhananov; Editing by Gerald E. McCormick)
Related posts:
Massive Debt Collapse with Author F. William Engdahl
Police stored almost 500 body parts from cases no longer being investigated
The war on terror is corrupting all it touches
Media Runs Defense For Corzine After MF Global Revelation
Brussels orders EU flag must fly over Whitehall every day... and we could be fined if we fail to com...
NYPD Officer Stabbed in Head 'Lucky'
Views: 0